Urolithiasis prevalence in the Russian Federation: analysis of trends over a 15-year period.
Incidence
Kidney stone
Prevalence
Russian Federation
Urolithiasis
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
12
02
2021
accepted:
07
05
2021
pubmed:
20
5
2021
medline:
19
2
2022
entrez:
19
5
2021
Statut:
ppublish
Résumé
To conduct a comparative analysis of the prevalence of urolithiasis in the Russian Federation. We analysed urolithiasis prevalence and incidence data from 2005 to 2019 (15 years) for the entire population of Russia. Data were provided by the 'Ministry of Health' of the Russian Federation. The prevalence and incidence of urolithiasis were collected and analysed for both adults and children for each region of the Russian Federation over this 15-year period. Statistical analysis was performed using the SPSS Statistics 21 software package (SPSS). Intergroup correlations and differences between samples in the studied parameters were considered significant at p < 0.05. A total of 656,911 and 889,891 urolithiasis cases were observed in 2005 and 2019, respectively, an increase in urolithiasis prevalence of 35.4% for the study period, with the growth rate that was fairly uniform. The incidence of urolithiasis in the Russian Federation was 176,773 in 2005, while 205,414 new urolithiasis cases were recorded in 2019, with a clear tendency to a rising incidence of urolithiasis, an increase of 16.2% during the study period. The incidence per 100,000 in children remained stable during the entire period of analysis. The incidence and prevalence of urolithiasis in the adult population steadily increased in all regions of the Russian Federation, while the incidence in children remained stable. The incidence of urolithiasis was associated with an increase in the incidence of diabetes mellitus, obesity and meat consumptions, highlighting the strong association of kidney stone disease with these risk factors.
Identifiants
pubmed: 34008087
doi: 10.1007/s00345-021-03729-y
pii: 10.1007/s00345-021-03729-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3939-3944Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Pak CYC (1998) Kidney stones. Lancet 351:1797–1801. https://doi.org/10.1016/S0140-6736(98)01295-1
doi: 10.1016/S0140-6736(98)01295-1
pubmed: 9635968
Stamatelou KK, Francis ME, Jones CA, Nyberg Jr LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Clinical Nephrology – Epidemiology – Clinical Trials 63:1817–1823. https://doi.org/10.1046/j.1523-1755.2003.00917.x
Rukin NJ, Siddiqui ZA, Chedgy ECP, Somani BK (2017) Trends in upper tract stone disease in England: evidence from the hospital episodes statistics database. Urol Int 98:391–396. https://doi.org/10.1159/000449510
doi: 10.1159/000449510
pubmed: 27694759
Abrahams HM, Meng MV, Stoller ML (2007) Urinary stone inhibitors. In: Urinary stone disease, pp 157–173. https://doi.org/10.1007/978-1-59259-972-1_9
Morgan MSC, Pearle MS (2016) Medical management of renal stones. BMJ 352:1–12. https://doi.org/10.1136/bmj.i52
doi: 10.1136/bmj.i52
Ramello A, Vitale C, Marangelle M (2000) Epidemiology of nephrolithiasis. J Nephrol 13:45–50
Prezioso D, Illiano E, Piccinocchi G, Cricelli C, Piccinocchi R, Saita A et al (2014) Urolithiasis in Italy: an epidemiological study. Arch Ital Di Urol e Androl 86:99–102. https://doi.org/10.4081/aiua.2014.2.99
doi: 10.4081/aiua.2014.2.99
Chirag ND, Schwartz BF, Talavera F (2020) Nephrolithiasis. https://emedicine.medscape.com/article/437096-overview#showall
Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367:333–344. https://doi.org/10.1016/S0140-6736(06)68071-9
doi: 10.1016/S0140-6736(06)68071-9
pubmed: 16443041
Shin S, Srivastava A, Alli NA, Bandyopadhyay BC (2018) Confounding risk factors and preventative measures driving nephrolithiasis global makeup. World J Nephrol 7(7):129–142. https://doi.org/10.5527/wjn.v7.i7.129
doi: 10.5527/wjn.v7.i7.129
pubmed: 30510912
pmcid: 6259033
Wong Y, Cook P, Roderick P, Somani BK (2016) Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol 30(3):246–253
doi: 10.1089/end.2015.0567
Ghani KR, Sammon JD, Karakiewicz PI, Sun M, Bhojani N, Sukumar S et al (2013) Trends in surgery for upper urinary tract calculi in the USA using the Nationwide Inpatient Sample: 1999–2009. BJU Int 112:224–230. https://doi.org/10.1111/bju.12059
doi: 10.1111/bju.12059
pubmed: 23480795
Pietropaolo A, Proietti S, Geraghty R, Skolarikos A, Papatsoris A, Liatsikos E et al (2017) Trends of ‘urolithiasis: interventions, simulation, and laser technology’ over the last 16 years (2000–2015) as published in the literature (PubMed): a systematic review from European section of Uro-technology (ESUT). World J Urol 35:1651–1658. https://doi.org/10.1007/s00345-017-2055-z
doi: 10.1007/s00345-017-2055-z
pubmed: 28593477
pmcid: 5649597
Geraghty RM, Jones P, Somani BK (2017) Worldwide trends of urinary stone disease treatment over the last two decades: a systematic review. J Endourol 31:547–556. https://doi.org/10.1089/end.2016.0895
doi: 10.1089/end.2016.0895
pubmed: 28095709
Gamage KN, Jamnadass E, Sulaiman SK, Pietropaolo A, Aboumarzouk O, Somani BK (2020) The role of fluid intake in the prevention of kidney stone disease: A systematic review over the last two decades. Turk J Urol 46:92–103
doi: 10.5152/tud.2020.20155
Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N et al (2014) Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: A randomized controlled trial comparing DASH (dietary approaches to stop hypertension)-style and low-oxalate diets. Am J Kidney Dis 63:456–463. https://doi.org/10.1053/j.ajkd.2013.11.022
doi: 10.1053/j.ajkd.2013.11.022
pubmed: 24560157
Geraghty RM, Cook P, Walker V, Somani BK (2020) Evaluation of the economic burden of kidney stone disease in the UK: a retrospective cohort study with a mean follow-up of 19 years. BJU Int 125:586–594. https://doi.org/10.1111/bju.14991
doi: 10.1111/bju.14991
pubmed: 31916369
Geraghty RM, Jones P, Herrmann TRW, Aboumarzouk O, Somani BK (2018) Ureteroscopy is more cost effective than shock wave lithotripsy for stone treatment: Systematic review and meta-analysis. World J Urol 36:1783–1793. https://doi.org/10.1007/s00345-018-2320-9
doi: 10.1007/s00345-018-2320-9
pubmed: 29730839
pmcid: 6208679
Manuel Ferraro MBP (2021) Dietetic and lifestyle recommendations for stone formers. Arch Esp Urol 74:112–122
New F, Somani BK (2016) A complete world literature review of quality of life (QOL) in patients with kidney stone disease (KSD). Curr Urol Rep 17:1–6. https://doi.org/10.1007/s11934-016-0647-6
doi: 10.1007/s11934-016-0647-6